The signaling pathways for cell survival are much less well understood than those for apoptosis [1] . Many mammalian cell-survival factors have been identified, either biochemically or from genetic studies in other organisms. Effective genetic methods that allow systematic study of anti-apoptosis genes in mammalian cells remain to be established, however. To achieve this goal, we used a new genetic screening method using enhanced retroviral mutagen (ERM) vectors to identify factors that mediate IL-3-dependent survival of hematopoietic cells. Both known and novel mediators of cell survival were identified, including Bcl-x L , phosphatidylinositide 3-kinase (PI 3-kinase), Akt and cytokine-independent survival kinase (CISK). CISK is a PX-domain-containing serine/threonine kinase homologous to serum-and glucocorticoid-regulated protein kinase (SGK). We showed that CISK acts downstream of the PI 3-kinase cascade in vivo and may function in parallel to Akt by phosphorylating Bad and the transcription factor FKHRL1. The distinct subcellular localization of CISK, however, suggests that it acts in different signaling cascades from Akt. Our results demonstrate the power of ERM to identify key genes involved in cell-survival signaling. Furthermore, CISK is the first SGK family member that has been shown to promote survival, pointing to the possibility that other SGK family proteins may also function in survival pathways. 
The new large-scale mammalian genetic screening method we have developed takes advantage of the random nature of retroviral integration and uses engineered sequences to mutagenize endogenous genes. Several features were engineered into the ERM vectors ( Figure 1 ) as an improvement on conventional retroviral vectors [2] . A mutagenesis tag (ERM Tag) and a splice donor sequence were added in the U3 region of the 3′ long terminal repeat (LTR) to tag endogenous genes. The ERM Tag sequences include an epitope tag and a myristylation signal to increase mutagenesis efficiency, and to allow direct cloning of the targeted genes by RT-PCR. Furthermore, expression of the ERM Tag was controlled by a promoter that could be turned off by tetracycline [3] , making the ERM system conditional and enabling analysis of authentic integration events rather than spontaneous mutations. Insertional gene activation by ERM integration may occur either through the generation of a fusion molecule between ERM Tag and endogenous sequences (via the engineered splice donor), or by transcriptional activation of the endogenous genes (via the ERM retroviral enhancer) ( Figure 1 ).
The ERM strategy was used to screen for anti-apoptosis genes in IL-3-dependent 32D cells. A set of three ERM constructs in three reading frames was constructed to generate viruses for infection of 32D cells (multiplicity of infection < 1) which undergo apoptosis upon withdrawal of IL-3 (see Supplementary material for full methodological details). Approximately 100 mutant clones were isolated. Design of the ERM vector. The ERM constructs are pBabe-puro based vectors as shown at the top. Sequences that encode the splice donor (SD), ERM Tag (epitope tag and myristylation signal), and the tetracycline-responsive promoter are represented by boxes in the 5′ region of the 3′ LTR. The arrow indicates the direction of transcription. During ERM replication by reverse transcription, the engineered sequences are duplicated to the 5′ LTR as well. ERM virus integration may either occur close to an endogenous exon, allowing splicing and generation of fusion products, or result in increased transcription of the locus as a result of the activity of the ERM enhancer. SA, splice acceptor. [4] , c-Abl [5] , PI 3-kinase and Akt/PKB [6, 7] ) have been implicated in the IL-3 pathway. One of the novel survival mediators is a serine/threonine kinase we named CISK (Figure 2a) . CISK is homologous to SGK [8] , but, unlike SGK, it contains a putative amino-terminal Phox-homology (PX) domain found in NADPH oxidase and sorting nexins [9, 10] . The kinase domain of CISK is also very similar to Akt (51%). Notably, the two regulatory residues shown to be important for modulating SGK (Thr256 and Ser421) and Akt (Thr308 and Ser473) activities are also conserved in CISK (Thr320 and Ser486). CISK appears to be widely expressed, predominantly in the mouse heart, spleen and 7-day embryo.
CISK is likely to be the mouse homolog of human SGK3. The carboxy-terminal sequence (from Met68) of CISK is 96% identical to hSGK3, whose cellular function remains unknown [11] . However, the CISK amino-terminal 67 amino acids encode half of the predicted PX domain and are absent from the reported hSGK3 sequence. This difference in length may be accounted for by a difference in translational start sites. To determine whether Met1 or Met68 is utilized as the initial methionine, full-length CISK mRNA was translated in vitro as well as expressed in 293T cells. In both systems the predominant CISK product was ~65 kDa, consistent with Met1 being the initial methionine ( Figure 2a ). These data suggest that the reported hSGK3 may be a partial sequence.
Because the ERM promoter was tetracycline regulatable (Figure 1 ), the original CISK clone isolated during the screen was tested for tetracycline responsiveness. This was positive (Figure 2b ), indicating that CISK was the retrovirally targeted gene responsible for the survival phenotype. The anti-apoptotic function of CISK did not involve an autocrine mechanism (data not shown). In addition, expression of either wild-type or activated (myristylated) CISK was able to protect 32D cells after IL-3 withdrawal (Figure 2c ). Activated CISK could also protect IL-3-dependent BAF3 cells. Furthermore, a kinase-dead CISK mutant (K191A) did not inhibit cell death, suggesting that the kinase activity is critical. In contrast, deletion of the PX domain (Myr-CISK∆PX) consistently enhanced survival, suggesting that this domain may negatively regulate CISK activity. The identification of CISK from our survival screen provided the first clue to CISK function. It also raised the intriguing possibility that other SGK family kinases may also regulate cell survival.
The sequence homology between CISK and Akt suggests a role of CISK in PI 3-kinase survival pathways, possibly interacting with Akt substrates. Indeed, we found that CISK specifically phosphorylates histone H2B in a kinasedependent manner. We next investigated whether the kinase activity of CISK might be regulated by IL-3 and PI 3-kinase. As shown in Figure 2d , an almost 7 ± 1.2-fold increase in H2B phosphorylation could be detected within 1 minute after IL-3 addition in 32D cells expressing wildtype CISK. Importantly, such activation was almost completely abolished by wortmannin. These data show that the activity of CISK can be regulated by IL-3, and support the notion that CISK has a role in IL-3-mediated survival downstream of PI 3-kinase and possibly overlapping in function with Akt.
One target of Akt in vivo is the forkhead family of transcription factors (FKHRs) such as FKHRL1 [12] . FKHRs may upregulate Fas ligand and thereby induce apoptosis. Supporting the model that CISK may have overlapping functions with Akt and target FKHRs, co-expression of activated or wild-type CISK and FKHRL1 resulted in dose-dependent inhibition of FKHRL1 activity (Figure 3a) . Furthermore, kinase-dead CISK failed to inhibit FKHRL1 activity. Therefore, CISK can target FKHRs in vivo, probably contributing to its anti-apoptosis activity.
IL-3 has been shown to increase expression of Bcl-x L and Bcl-2 [13, 14] . CISK may therefore promote survival by regulating Bcl-2 family proteins. Increased levels of Bcl-x L were sustained in cells expressing activated CISK (Figure 3b ), supporting this hypothesis. The level of Bcl-2 was also slightly increased (data not shown). IL-3 and Akt can induce Bad phosphorylation, which in turn promotes homodimerization of Bcl-x L or Bcl-2, thereby attenuating All clones shown are tetracycline responsive. *TF, targeting frequency, indicating the number of independent clones in which the gene was identified. † RF, the reading frame of the ERM Tag sequences in the original ERM construct (three ERM constructs in three reading frames were used for the screen). ‡ GM-CSFR, receptor for granulocytemacrophage colony-stimulating factor.
cell death [7, 15] . We found that expression of activated CISK resulted in an increase in the amount of phosphorylated Bad (Figure 3b ). These data strongly indicate that CISK may mediate cell survival function through modulating Bcl-2 family proteins. Such interactions, however, did not appear to require Akt activation. The level of phosphorylated Akt did not change in cells expressing myristylated CISK (Figure 3b ), suggesting that CISK may function in parallel to Akt.
The unique domain organization of CISK suggests that it may function in pathways distinct from Akt. The distinct subcellular localization of CISK supports this hypothesis.
In agreement with previous findings [16] , we found that Akt was localized to the cytoplasm and nucleus in the presence of serum, with larger amounts in the nucleus (Figure 3c ). In contrast, CISK appeared to be localized in vesicular compartments, consistent with the localization of many PX-domain-containing sorting proteins such as SNX [17] . In addition, the PX domain is required for CISK subcellular localization, because truncation of the PX domain resulted in diffused staining (Figure 3c ). These data indicate that CISK and Akt may function differently. Interestingly, the addition of a myristylation signal to full-length CISK did not significantly change its localization (Figure 3d ), suggesting a dominant role for the PX domain in targeting CISK.
We have used the ERM genetic screening method to search for survival genes throughout the genome. Examination of the remaining ~60 clones may yield more survival genes, including those in the Ras and MAP kinase cascades, the IAP family, or the JAK/STAT pathway. Our results demonstrate the reliability and power of this approach to gene identification compared with conventional retroviral mutagenesis [18] . The ERM screen has also been successful in identifying transforming genes in NIH 3T3 cells (our unpublished work). The method can therefore be adapted for screening genes involved in diverse signaling pathways.
We present here the first evidence that CISK, a member of the SGK family, can effectively block apoptosis induced by IL-3 withdrawal. Other SGK family kinases lack the PX domain and their involvement in cell-survival signaling remains to be determined. CISK may prevent cell death by upregulating Bcl-x L expression and inhibiting the pro-apoptotic proteins Bad and FKHRs. CISK probably directly phosphorylates Bad and FHKRs, as these proteins contain the CISK consensus phosphorylation site (RXRXXS/T, where X is any amino acid) [11] . Because CISK expression does not involve Akt activation, and Bad and FKHRs are also Akt substrates, our findings strongly indicate that CISK functions in parallel to Akt. Although CISK and Akt share some similarities, they are distinct kinases. Akt has an amino-terminal pleckstrin-homology (PH) domain, and the activation of Akt mainly depends on direct binding of the PH domain to D3-phosphoinositide lipids and phosphorylation by 3-phosphoinositide-dependent kinase 1 (PDK1) [19] . On the basis of sequence homology between CISK, Akt and other SGKs, CISK probably acts directly downstream of PDK1. However, CISK contains a PX domain, which may function similarly to the PH domain, or act as a protein-protein interaction domain and recruit signaling molecules other than phospholipids [10] . If the latter is the case, CISK may respond to and integrate other cellsurvival signals in addition to PI 3-kinase and thereby function in pathways distinct from Akt. Consistent with this, we found that the localization of CISK depended on its PX domain and differed from that of Akt. The differential subcellular localization of CISK and Akt may thus allow these two kinases to be regulated by and target different pathways. 
Supplementary material

